Mavacoxib is a selective cyclooxygenase 2 inhibitor used as a pharmaceutical raw material in veterinary medicine. It is a pyrazole derivative containing sulfonamide and organofluorine functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Mavacoxib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Celecoxib
pharmaceutical raw material
Aprepitant
pharmaceutical raw material
Ipamorelin
pharmaceutical raw material
Doxycycline monohydrate
pharmaceutical raw material
Roblitinib
pharmaceutical raw material
CHEMBL29923
pharmaceutical raw material
4-Desmethyl-2-methyl Celecoxib
pharmaceutical intermediate
2,5-Dimethylcelecoxib
pharmaceutical raw material
The international HS code for Mavacoxib (CAS 170569-88-7) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
TTZNQDOUNXBMJV-UHFFFAOYSA-N
C1=CC(=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F)F
Sourcing Mavacoxib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.